Overview

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to assess the efficacy of LEO 32731 cream 20 mg/g compared with LEO 32731 cream vehicle in adults with mild to moderate AD after 3 weeks of treatment.
Phase:
Phase 1
Details
Lead Sponsor:
LEO Pharma